Filing Details
- Accession Number:
- 0000914475-15-000014
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-01-09 16:30:44
- Reporting Period:
- 2015-01-08
- Filing Date:
- 2015-01-09
- Accepted Time:
- 2015-01-09 16:30:44
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 914475 | Neurocrine Biosciences Inc | NBIX | Biological Products, (No Disgnostic Substances) (2836) | 330525145 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1343124 | Flint Christopher Obrien | Neurocrine Biosciences, Inc. 12780 El Camino Real San Diego CA 92130 | Chief Medical Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2015-01-08 | 20,000 | $2.59 | 116,544 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2015-01-08 | 20,000 | $27.11 | 96,544 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2015-01-08 | 20,000 | $2.59 | 116,544 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2015-01-08 | 20,000 | $27.11 | 96,544 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2015-01-08 | 15,000 | $2.59 | 111,544 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2015-01-08 | 15,000 | $27.50 | 96,544 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Incentive Stock Option | Disposition | 2015-01-08 | 20,000 | $2.59 | 20,000 | $2.59 |
| Common Stock | Incentive Stock Option | Disposition | 2015-01-08 | 20,000 | $2.59 | 20,000 | $2.59 |
| Common Stock | Incentive Stock Option | Disposition | 2015-01-08 | 15,000 | $2.59 | 15,000 | $2.59 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 35,000 | 2017-05-11 | No | 4 | M | Direct | |
| 15,000 | 2017-05-11 | No | 4 | M | Direct | |
| 0 | 2017-05-11 | No | 4 | M | Direct |
Footnotes
- The disposition reported in this Form 4 was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person at least 90 days prior to the transaction date in Box 3 above. Additionally, Issuer policy restricts the Reporting Person from amending, canceling, suspending or otherwise modifying any 10b5-1 trading plan subsequent to adoption of the plan.
- The option was granted May 11, 2010 and vested in 36 equal monthly installments beginning June 11, 2010.
Billionaire Hedge Funds
